Literature DB >> 11314260

Enhanced detection of beta-galactosidase reporter activation is achieved by a reduction of hemoglobin content in tissue lysates.

D A Nazarenko1, S D Dertinger, T A Gasiewicz.   

Abstract

beta-galactosidase (beta-gal), the product of the E. coli LacZ gene, has been used extensively as a reporter in numerous systems. Until recently, the most commonly used method of detecting beta-gal reporter enzymatic activity was a colormetric assay based on the cleavage of the beta-gal substrate 5-bromo-4-chloro-3-indolyl beta-D-galactopyranoside (X-gal) to form a blue precipitate. However, when increased sensitivity is needed, many investigators now turn to alternate substrates that produce fluorescent or luminescent products upon cleavage by beta-gal. These products are much more easily quantified than X-gal. The luminescent and fluorometric assays work very well in cultured cells but are often less sensitive in whole tissue lysates. In this study, we have evaluated the sensitivity of a fluorescent and a luminescent substrate in whole tissue lysates cleared of red blood cells or washed with PBS only. We have found that both assays show increased low-end sensitivity in tissues with reduced levels of hemoglobin (Hb). Hb is apparently able to quench luminescent and, to a lesser degree, fluorescent reporter light emission. Therefore, steps should be taken to reduce Hb levels either by lysis, perfusion, or both to enhance the sensitivity of these assays.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11314260     DOI: 10.2144/01304st03

Source DB:  PubMed          Journal:  Biotechniques        ISSN: 0736-6205            Impact factor:   1.993


  3 in total

Review 1.  Synthetic biology devices for in vitro and in vivo diagnostics.

Authors:  Shimyn Slomovic; Keith Pardee; James J Collins
Journal:  Proc Natl Acad Sci U S A       Date:  2015-11-24       Impact factor: 11.205

2.  Genetically modified whole-cell bioreporters for environmental assessment.

Authors:  Tingting Xu; Dan M Close; Gary S Sayler; Steven Ripp
Journal:  Ecol Indic       Date:  2013-05-01       Impact factor: 4.958

3.  Phage-based platforms for the clinical detection of human bacterial pathogens.

Authors:  David A Schofield; Natasha J Sharp; Caroline Westwater
Journal:  Bacteriophage       Date:  2012-04-01
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.